Psychology Department, Oklahoma State University, Stillwater, Oklahoma.
Division of Endocrinology, Department of Internal Medicine, University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil.
Endocr Rev. 2019 Dec 1;40(6):1547-1572. doi: 10.1210/er.2019-00049.
Differences/disorders of sex development (DSD) are a heterogeneous group of congenital conditions that result in discordance between an individual's sex chromosomes, gonads, and/or anatomic sex. Advances in the clinical care of patients and families affected by 46,XY DSD have been achieved since publication of the original Consensus meeting in 2006. The aims of this paper are to review what is known about morbidity and mortality, diagnostic tools and timing, sex of rearing, endocrine and surgical treatment, fertility and sexual function, and quality of life in people with 46,XY DSD. The role for interdisciplinary health care teams, importance of establishing a molecular diagnosis, and need for research collaborations using patient registries to better understand long-term outcomes of specific medical and surgical interventions are acknowledged and accepted. Topics that require further study include prevalence and incidence, understanding morbidity and mortality as these relate to specific etiologies underlying 46,XY DSD, appropriate and optimal options for genitoplasty, long-term quality of life, sexual function, involvement with intimate partners, and optimizing fertility potential.
性发育障碍(DSD)是一组异质性先天性疾病,导致个体的性染色体、性腺和/或解剖性别之间存在不一致。自 2006 年首次共识会议发表以来,46,XY DSD 患者及其家庭的临床护理得到了改善。本文旨在回顾 46,XY DSD 患者的发病率和死亡率、诊断工具和时机、养育性别、内分泌和手术治疗、生育和性功能以及生活质量方面的已知情况。承认并接受多学科保健团队的作用、建立分子诊断的重要性以及利用患者登记处进行研究合作的必要性,以便更好地了解特定医疗和手术干预的长期结果。需要进一步研究的主题包括患病率和发病率、了解发病率和死亡率,因为这些与 46,XY DSD 潜在的具体病因有关、适当和最佳的生殖器整形选择、长期生活质量、性功能、与亲密伴侣的关系以及优化生育能力。